241 Utilizing real-world evidence to increase efficiency of randomized controlled trials with application to repurposed therapeutics for COVID-19
OBJECTIVES/GOALS: We aim to extend a novel statistical method called the Semi-Supervised Mixture Multisource Exchangeability Model (SS-MIX-MEM) and to implement the SS-MIX-MEM approach to supplement ALPS-COVID data with N3C data to achieve analyses with greater precision and actionable conclusions....
Main Authors: | Lillian M F Haine, Thomas A Murray, Joseph S Koopmeiners |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-04-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866122001297/type/journal_article |
Similar Items
-
Totality of evidence of the effectiveness of repurposed therapies for COVID‐19: Can we use real‐world studies alongside randomized controlled trials?
by: Jaap Mandema, et al.
Published: (2023-10-01) -
High-throughput target trial emulation for Alzheimer’s disease drug repurposing with real-world data
by: Chengxi Zang, et al.
Published: (2023-12-01) -
The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod
by: Patmanathan, S.N., et al.
Published: (2015) -
Autonomous artificial intelligence increases real-world specialist clinic productivity in a cluster-randomized trial
by: Michael D. Abramoff, et al.
Published: (2023-10-01) -
Vaginismus Treatment: Clinical Trials Follow Up 241 Patients
by: Peter T. Pacik, MD, FACS, IF, et al.
Published: (2017-06-01)